SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Techniclone (TCLN) -- Ignore unavailable to you. Want to Upgrade?

To: shero who wrote (997)1/5/1998 12:59:00 PM
From: Roger Mathias  Read Replies (2) | Respond to of 3702
 
I think Tustin should take a proactive stance and go out of their way to notify every Cancer referral service in the country of their products in testing. I think that the testing centers would be mobbed with potential patients and the test pool would be huge. Obviously, the sooner Techniclone can prove efficacy in large numbers, the sooner the drugs will be approved. Think of the lives that could be saved.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News